Skip to main content

Karen Gripp, Peter Krawitz

FDNA has appointed Karen Gripp as CMO and Peter Krawitz as chief data science officer. The maker of the Face2Gene suite of next-generation phenotyping (NGP) applications said in a statement that their combined clinical, research, and development experience "will elevate the use and proven success of NGP technologies that capture, structure, and interpret complex physiological information." Gripp is chief of medical genetics at the AI duPont Hospital for Children and a professor of pediatrics at the Sidney Kimmel Medical College at Thomas Jefferson University. Krawitz is director of the Institute for Genomic Statistics and Bioinformatics at the University of Bonn in Germany and has been working with FDNA on a study called Prioritization of Exome Data By Image Analysis, or PEDIA, to determine the impact of phenotype and facial analysis on molecular interpretation.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.